FdaApplication
ANDA 210692
Identifiers
- fda_app_no: ANDA210692
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2018-10-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATOVAQUONE | ATOVAQUONE | 750MG/5ML | SUSPENSION;ORAL |
1 product